Company profile · Biotech & medical
和康生物科技股份有限公司 · 1783
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Maxigen Biotech engages in the research, manufacturing, and sales of biopolymer materials applied to biomedical materials and medical beauty skincare products.[1]
The company was established on 87/12/03.[1]
The company was listed on 102/12/20.[1]
The company is located in Taoyuan City 333, Taiwan (R.O.C.).[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$74m | +17.3% | -15.6% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$1m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | MAXIGEN BIOTECH INC. |
|---|---|
| Chinese name | 和康生物科技股份有限公司 |
| Stock code | 1783 (TWSE) |
| Industry | Biotech & medical |
| Founded | 03 Dec 1998 |
| Listed | 20 Dec 2013 |
| Paid-in capital | NT$897m |
| Chairman | 林詠翔 |
| President | 陳敬亭 |
| Headquarters | No.88, Keji 1st Rd., Guishan Dist., Taoyuan City 333, Taiwan (R.O.C.) |
| Website | https://www.mbi.com.tw |
| Official business description | 生物高分子材料應用於生物醫材及醫美保養品的研發、製造及銷售 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.